HHS revives long-defunct task force on safer childhood vaccines

15 August 2025

The US Department of Health and Human Services has reinstated the Task Force on Safer Childhood Vaccines, a panel created by Congress to strengthen the safety, quality and oversight of vaccines given to American children. The original group was disbanded in 1998.

The task force will be chaired by National Institutes of Health director Jay Bhattacharya, with senior leaders from the Food and Drug Administration and the Centers for Disease Control and Prevention also serving. “By reinstating this Task Force, we are reaffirming our commitment to rigorous science, continuous improvement, and the trust of American families,” said Mr Bhattacharya.

Working with the Advisory Commission on Childhood Vaccines, the panel will focus on developing, refining and promoting vaccines that have fewer and less serious side effects than those now in use. It will also target improvements in manufacturing, distribution and safety monitoring. The first formal report to Congress is due in two years, followed by biennial updates.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight



More Features in Pharmaceutical